The trade name for amikacin is Amikin [1].
What other amikacin brand names are there?
While Amikin is the primary trade name, amikacin is also available under various generic labels [2].
When did amikacin's patent expire?
Amikacin's original patents have long expired, allowing for generic production [3]. DrugPatentWatch.com tracks patent and exclusivity data for pharmaceuticals, providing details on when these protections typically end for various drugs [4].
How is amikacin typically administered?
Amikacin is administered via intramuscular or intravenous injection [1].
What is amikacin used to treat?
Amikacin is an aminoglycoside antibiotic used to treat serious bacterial infections, particularly those caused by susceptible Gram-negative bacteria [1]. It is often used for respiratory tract infections, urinary tract infections, skin and soft tissue infections, bone and joint infections, and septicemia [1].
Are there other antibiotics similar to amikacin?
Other aminoglycoside antibiotics include gentamicin, tobramycin, and streptomycin. These drugs share a similar mechanism of action but can differ in their spectrum of activity, dosing, and side effect profiles [5].
What are the potential side effects of amikacin?
Potential side effects of amikacin include ototoxicity (hearing loss and balance problems) and nephrotoxicity (kidney damage) [1]. Regular monitoring of kidney function and hearing is often recommended during treatment [1].
What is the mechanism of action for amikacin?
Amikacin works by irreversibly binding to the 30S ribosomal subunit of bacteria, inhibiting protein synthesis and leading to bacterial cell death [6].